1. Su, Yang, Zhang, Xin, Bidlingmaier, Scott, Lee, Nam-Kyung, Liu, Bin. 2020. ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen. In Cancer research, 80, 4552-4564. doi:10.1158/0008-5472.CAN-20-1418. https://pubmed.ncbi.nlm.nih.gov/32868383/
2. Shin, Hye-Su, Jung, Sang Baek, Park, Sungho, Dua, Pooja, Lee, Dong Ki. 2019. ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles. In Molecular therapy. Methods & clinical development, 15, 204-210. doi:10.1016/j.omtm.2019.08.016. https://pubmed.ncbi.nlm.nih.gov/31687420/
3. Liu, Shuang, Mao, Qinsheng, Xue, Wanjiang, Chen, Pei, Zhou, Qing. 2018. High expression of ALPPL2 is associated with poor prognosis in gastric cancer. In Human pathology, 86, 49-56. doi:10.1016/j.humpath.2018.11.019. https://pubmed.ncbi.nlm.nih.gov/30496798/
4. Bi, Yan, Tu, Zhifen, Zhang, Yanping, Wang, Yixuan, Gao, Shaorong. . Identification of ALPPL2 as a Naive Pluripotent State-Specific Surface Protein Essential for Human Naive Pluripotency Regulation. In Cell reports, 30, 3917-3931.e5. doi:10.1016/j.celrep.2020.02.090. https://pubmed.ncbi.nlm.nih.gov/32187559/
5. Hsu, Ping-Ching, Daughters, Stacey B, Bauer, Michael A, Su, L Joseph, Addicott, Merideth A. 2023. Association of DNA methylation signatures with cognitive performance among smokers and ex-smokers. In Tobacco induced diseases, 21, 106. doi:10.18332/tid/168568. https://pubmed.ncbi.nlm.nih.gov/37605769/